Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance

Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance

Regular physical activity is vital for normal paediatric somatic growth, cardiovascular development, bone mineral density accrual, metabolic regulation, and emotional well-being. The paediatrician plays a central role both in advocating for population-level active living and in conducting rigorous pre-participation physical evaluations (PPE) to identify rare, life-threatening conditions before young athletes enter competitive sports.

Furthermore, modern paediatric sports medicine emphasizes that chronic disease—including asthma, Type 1 diabetes, congenital heart disease, and bleeding disorders—is rarely an absolute contraindication to athletic participation. Instead, structured, condition-specific clearance and proactive management allow children with chronic illnesses to reap the full physiological and psychosocial benefits of sports safely.

---

Paediatric Physical Activity Guidelines

The World Health Organization (WHO) and the European Academy of Paediatrics (EAP) have established evidence-based physical activity benchmarks for children and adolescents (ages 5 to 17 years):

---

Pre-Participation Cardiovascular Screening

Sudden Cardiac Death (SCD) in a young athlete is an infrequent but catastrophic event, with an estimated incidence of 1 in 50,000 to 1 in 100,000 participant-years. The underlying etiology in young athletes ($<35$ years) is predominantly congenital or inherited structural and electrical cardiovascular anomalies, contrasting sharply with the atherosclerotic coronary artery disease seen in older adults.

Primary Etiologies of SCD in Young Athletes

1. Hypertrophic Cardiomyopathy (HCM): Asymmetric septal hypertrophy predisposing to dynamic left ventricular outflow tract (LVOT) obstruction and malignant ventricular arrhythmias (most common cause in North American registries).
2. Anomalous Origin of a Coronary Artery (AOCA): Particularly the left main coronary artery arising aberrantly from the right sinus of Valsalva, coursing between the aorta and pulmonary trunk; acute exercise dilates the great vessels, compressing the anomalous slit-like lumen and causing myocardial ischemia.
3. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Fibrofatty replacement of right ventricular myocardium; exercise accelerates desmosomal disruption and triggers ventricular tachycardia.
4. Inherited Ion Channelopathies: Long QT Syndrome (LQTS), Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
5. Myocarditis: Acute viral myocardial inflammation predisposing to lethal ventricular fibrillation during exertion.
6. Marfan Syndrome: Cystic medial necrosis leading to progressive aortic root dilation, aortic regurgitation, and catastrophic aortic dissection/rupture.
7. Commotio Cordis: Ventricular fibrillation triggered by a blunt, non-penetrating blow to the precordium directly over the cardiac silhouette during the vulnerable upstroke of the T-wave (15–30 ms prior to T-wave peak).

Critical Screening History Red Flags

A careful history is essential, but history and examination alone can miss silent cardiac disease. The presence of any of the following mandatory red flags warrants immediate sports disqualification and urgent referral to a paediatric cardiologist:

• Personal History:
  • Unexplained syncope or near-syncope, specifically occurring during or immediately following peak physical exertion (vasovagal syncope typically occurs after exercise or during prolonged quiet standing, whereas exertional syncope during effort signifies high-risk cardiac outflow obstruction or arrhythmia).
  • Exertional chest pain, tightness, or pressure.
  • Excessive, unexplained exertional dyspnea, fatigue, or palpitations disproportionate to conditioning level.
• Family History:
  • Premature sudden unexplained death in one or more first- or second-degree relatives before age 40 to 50 years (including unexplained drowning, single-vehicle motor collisions, or sudden infant death).
  • Known family history of cardiomyopathy (HCM, DCM, ARVC), Long QT syndrome, Brugada syndrome, severe unexplained arrhythmias, pacemaker/ICD placement at young age, or Marfan syndrome.

---

Targeted Physical Examination and Dynamic Auscultation

A focused cardiovascular examination must be conducted methodically on every athlete:

1. Vital Signs & Blood Pressure: Measure resting blood pressure with a suitable cuff. In European guidance, hypertension is BP ≥95th percentile for age/sex/height under 16 years, or ≥140/90 mmHg from 16 years. Confirm raised readings with repeated proper measurements before diagnosis/staging.
2. Vascular Examination: Simultaneous palpation of radial and femoral pulses. A noticeable delay or diminution of the femoral pulse (radio-femoral delay) or lower extremity blood pressure significantly lower than upper extremity pressure diagnosticates coarctation of the aorta.
3. Marfanoid Stigmata: Visual inspection for systemic features of Marfan syndrome: tall, slender habitus, pectus excavatum or carinatum, high-arched palate, scoliosis, arm span exceeding height ($>1.05$), and positive wrist sign (Walker-Murdoch) and thumb sign (Steinberg).
4. Dynamic Auscultation: Differentiating innocent (physiological) flow murmurs from pathological murmurs—most notably hypertrophic cardiomyopathy—requires dynamic positional maneuvers that alter cardiac hemodynamics.

+--------------------------------------------------------------------------+
|               DYNAMIC AUSCULTATION: HCM VS INNOCENT MURMUR               |
|                                                                          |
|   Maneuver                  Preload / LV Cavity Size    HCM Murmur       |
|   ───────────────────────────────────────────────────────────────────    |
|   Abrupt Standing           Decreased Preload           INCREASES        |
|   Valsalva (Strain Phase)   Decreased Preload           INCREASES        |
|   Squatting                 Increased Preload/Afterload DECREASES        |
|   Passive Leg Raise         Increased Preload           DECREASES        |
|   Isometric Handgrip        Increased Afterload         DECREASES        |
+--------------------------------------------------------------------------+

Mechanism of the Dynamic HCM Murmur

The systolic murmur of HCM originates from dynamic left ventricular outflow tract (LVOT) obstruction caused by the anterior leaflet of the mitral valve being drawn toward the hypertrophied interventricular septum by Venturi forces (Systolic Anterior Motion [SAM]).

• Standing or Valsalva Strain: Reduces venous return to the heart, decreasing left ventricular end-diastolic volume. The smaller LV cavity brings the mitral valve into closer proximity to the hypertrophied septum, worsening the obstruction. Consequently, the murmur becomes harsher and louder.
• Squatting: Compresses femoral vessels and increases venous return (increased preload and increased systemic afterload). The expanded LV chamber separates the anterior mitral leaflet from the septum, relieving the obstruction. The murmur becomes distinctly softer or disappears.
• Contrast with Innocent Murmurs: Innocent flow murmurs (e.g., Still's vibratory murmur or pulmonary flow murmur) decrease in intensity upon standing because reduced stroke volume decreases turbulent blood velocity across normal valves.

---

European vs. North American ECG Screening Protocols

A notable divergence exists between European and North American cardiology guidelines regarding the inclusion of routine electrocardiography (ECG):

• Europe: EAPC/ESC–AEPC 2026 advises history, examination and resting 12-lead ECG from no later than 12 years, repeated every 2 years to 16; national implementation and resources vary.
• AHA/ACC 2025: Perform cardiovascular history/examination; adding ECG is reasonable when trained athlete-ECG interpretation and timely secondary evaluation are available. ECG is not reserved solely for a positive history. No screening programme excludes every cause of sudden cardiac arrest.

International Criteria for ECG Interpretation in Athletes

Athlete ECG interpretation must account for age, symptoms, family history and training. For athletes under 16, use the 2026 EAPC/ESC–AEPC paediatric framework; older athletes generally use adult International Criteria.

Pathological Q waves: Q/R ratio ≥0.25 or duration ≥40 ms in at least 2 leads, excluding III and aVR. Depth >3 mm alone is insufficient.

T-wave patterns: Anterior inversion in V1–V3 may be juvenile under 16. The 2026 paediatric framework permits V1–V4 under 12 and treats V1–V4 at 12–14 as borderline. In Black athletes, J-point/convex ST elevation followed by TWI confined to V1–V4 is a recognised normal pattern. Other anterior, lateral or inferior inversion needs age-appropriate specialist interpretation.

---

Sports Clearance in Chronic Paediatric Conditions

1. Exercise-Induced Bronchoconstriction (EIB) and Asthma

Exercise-induced bronchoconstriction results from rapid conditioning and humidification of large volumes of dry, cool air during exercise-induced hyperpnea, provoking mucosal dehydration, hyperosmolarity, and inflammatory mast cell mediator release (histamines, leukotrienes).

• Management Principles:
  • Children with well-controlled asthma must be encouraged to participate fully in all athletic sports.
  • Warm-Up Protocol: A structured 10- to 15-minute warm-up consisting of variable-intensity running induces a refractory period lasting up to 2 hours, during which mast cells are depleted of mediators.
  • Pharmacotherapy: Inhaled short-acting beta-2 agonist (SABA, e.g., salbutamol $200\,\mu\text{g}$ / 2 puffs) administered 10 to 15 minutes before exercise provides effective prophylaxis for 2 to 4 hours.
  • If an athlete requires pre-exercise SABA daily or experiences breakthrough symptoms, baseline daily controller therapy with inhaled corticosteroids (ICS) $\pm$ long-acting beta-2 agonists (LABA) or leukotriene receptor antagonists (montelukast) must be initiated or stepped up.
  • Cold-weather sports (cross-country skiing, ice hockey) carry the highest risk; athletes should wear thermal heat-exchange face masks when ambient temperatures are sub-freezing.

2. Type 1 Diabetes Mellitus (T1DM)

Physical activity profoundly influences glucose metabolism: aerobic exercise promotes insulin-independent glucose uptake via GLUT-4 translocation in skeletal muscle (predisposing to hypoglycemia), whereas intense anaerobic sprinting or competitive stress stimulates counter-regulatory catecholamines, provoking transient hyperglycemia.

• Pre-Exercise Blood Glucose & Ketone Algorithm:

T1DM: BEFORE EXERCISE

Glucose <5.0 mmol/L (<90 mg/dL):
  Take the planned rapid carbohydrate for body size and glucose trend.
  Recheck in 15 minutes; delay exercise until at least 5.0 mmol/L and stable.
  For hypoglycaemia (<3.9 mmol/L), follow the child's treatment plan
  (often ~0.3 g/kg glucose, up to 15 g), with reassessment after 15 minutes.

Glucose 5.0–15.0 mmol/L (90–270 mg/dL):
  Consider trend, insulin on board, activity and planned carbohydrate.
  Monitor regularly during exercise; this range is not a safety guarantee.

Glucose >15.0 mmol/L (>270 mg/dL): check blood ketones.
  ≥1.5 mmol/L: no exercise; follow the usual ketone-management plan.
  0.6–1.4 mmol/L: postpone, evaluate the cause and use the prescribed
    partial-correction/recheck plan before reconsidering exercise.
  <0.6 mmol/L: light/moderate activity may be possible with hydration,
    monitoring and the individual correction plan; avoid intense bursts.

Exercise during insulin-deficient ketosis can precipitate DKA.

• Insulin Dose Adjustments: Use an agreed plan based on exercise type/duration, meal timing and insulin on board. Meal-bolus reductions and advance pump-basal adjustments may help planned aerobic exercise, but the amount varies; do not automatically reduce insulin for every activity.
• Delayed Nocturnal Hypoglycemia: Muscle and liver glycogen resynthesis occurs 6 to 12 hours (and up to 24 hours) after strenuous exercise, creating a high risk of nocturnal hypoglycemia. Monitor overnight risk, particularly after prolonged late-day exercise. A bedtime snack and/or a planned basal reduction may help selected patients; neither is mandatory after every activity. Base the choice on glucose, insulin regimen and prior responses.

3. Congenital Heart Disease (CHD) and Sports Classification

Sports eligibility in children with repaired, palliated, or unoperated congenital heart defects is determined using the Mitchell / Bethesda Sports Classification System, which categorizes sports by their static (isometric, pressure load on LV) and dynamic (isotonic, volume load on cardiac output) components:

• Low Dynamic / Low Static (e.g., bowling, golf, riflery)
• High Dynamic / High Static (e.g., rowing, road cycling, decathlon, triathlon)
• Eligibility hinges on four core functional parameters: (1) degree of ventricular dysfunction, (2) presence of pulmonary arterial hypertension, (3) resting or exertional arterial oxygen desaturation, and (4) burden of ventricular arrhythmias.

4. Bleeding Disorders and Haemophilia

Children with bleeding disorders should not be arbitrarily restricted to a sedentary lifestyle. Physical activity strengthens dynamic peri-articular musculature, which paradoxically protects target joints against spontaneous hemarthroses.

• Sports Stratification:
  • Category 1 (Low Risk / Non-Contact): Swimming, golf, walking, badminton, table tennis. Usually encouraged after review of joint health and bleeding risk; continue prescribed prophylaxis and assess any additional coverage needed.
  • Category 2 (Moderate Risk / Controlled Contact): Soccer, basketball, baseball, gymnastics, cycling (with helmet and pads). Requires an individual haemophilia-team plan for haemostatic coverage, joint protection and supervision. A general factor trough goal above 3–5% or regular emicizumab does not by itself establish that a particular sport is safe.
  • Category 3 (High Risk / Collision & Combat): Rugby, American football, boxing, martial arts, ice hockey. Generally contraindicated in children with severe haemophilia due to unacceptably high risks of life-threatening intracranial hemorrhage or major internal organ hematoma.

5. Solitary Kidney and Mononucleosis / Splenomegaly

• Solitary Functioning Kidney: Historical bans on contact sports for children with a solitary kidney have been replaced by shared decision-making. The risk of traumatic renal loss in sports is exceedingly low (lower than the risk of head injury or bicycle accidents). Non-contact sports are unrestricted; contact/collision participation requires individual clinical judgement and informed family discussion. Flank padding may be considered, but has not been proven to prevent renal injury and does not replace risk assessment.
• Infectious Mononucleosis (Epstein-Barr Virus):
  • The spleen is enlarged in $>90\%$ of patients with acute EBV mononucleosis, even if not clinically palpable on physical exam.
  • Subcapsular splenic hemorrhage and catastrophic splenic rupture occur in ~0.1% to 0.5% of cases, with most ruptures occurring during the first month of illness; later rupture remains possible.
  • Return-to-Play Rules: All athletes must be strictly restricted from contact, collision, and heavy strenuous exertion for a minimum of 21 to 28 days from symptom onset.
  • Athletes may return to non-contact light conditioning after 3 to 4 weeks if they are completely afebrile, clinically asymptomatic, and have no palpable splenomegaly. Routine splenic ultrasound before sports clearance is not recommended unless physical examination remains equivocal in a high-risk collision athlete.